18 million British adults at risk of developing diabetes, analysis finds
New analysis from London Medical Laboratory has revealed up to 18 million UK adults could have prediabetes – which means they are on the verge
New analysis from London Medical Laboratory has revealed up to 18 million UK adults could have prediabetes – which means they are on the verge
Innovate UK, LifeArc, and Medicines Discovery Catapult (MDC) have joined forces to create PACE (Pathways to Antimicrobial Clinical Efficacy), a £30 million initiative supporting early-stage
As demand for weight-loss treatments intensifies, Eli Lilly has filed a complaint with the U.S. International Trade Commission against nearly a dozen online pharmacies that
MADRID — A novel type of immunotherapy from Amgen generated strong response rates in patients with advanced small cell lung cancer, results that could lead
How major risk factors relate to hospitalization or mortality.
Researchers are investigating how the most common type of breast cancer resists hormone therapy, thanks to new funding from Breast Cancer Now.
Researchers, policy-makers and business leaders from across the research and innovation community are invited to help tackle one of humanity’s biggest threats, anti-microbial resistance (AMR).
NHS boards across the UK are using a revolutionary technology to give GPs access to rapid advice from consultant dermatologists.
During a plenary lecture at the 26th World Congress of Neurology, Dr. Anthony Lang, professor of neurology and Jack Clark Chair for Parkinson’s Disease Research,
Clerkenwell Health, the modern mental health company specializing in matching patients with cutting-edge psychiatry treatments, today announced that it is taking part in Transcend Therapeutics’